What is the address of CARDIODNFLUX?

The registered office of CARDIODNFLUX is located at Rue Pêchières,Torgny 6, 6767 Rouvroy.

Is CARDIODNFLUX still active?

Yes. According to the CBE (30 October 2026) CARDIODNFLUX is active, legal situation “Normale toestand”, started on 19 March 2002.

Is CARDIODNFLUX registered on Peppol?

No, CARDIODNFLUX is currently not registered on the Peppol network.

What is the enterprise number of CARDIODNFLUX?

The enterprise number of CARDIODNFLUX is BE0477132211.

When was CARDIODNFLUX founded?

CARDIODNFLUX was founded on 19 March 2002.

Who are the directors of CARDIODNFLUX?

According to the 2025 annual accounts, the directors of CARDIODNFLUX are: Yvon DEHENEFFE.

Is CARDIODNFLUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 March 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CARDIODNFLUX make in 2025?

CARDIODNFLUX posted a profit after taxes of € 4,730 in financial year 2025.

What is the revenue of CARDIODNFLUX?

As a small company, CARDIODNFLUX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 12,183.

CARDIODNFLUX (Private Limited) - Rouvroy - BE0477132211

Dossier CARDIODNFLUX, printed on 30 October 2026 from databakkes.be/en/0477132211/cardiodnflux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

CARDIODNFLUX from Rouvroy, company number BE0477132211, closed financial year 2025 with a result of € 4,730 after tax. For that financial year CARDIODNFLUX recorded a gross margin of € 12,183 and equity of € 212,516. Compared with financial year 2024, the result moved from € 1,016 to € 4,730. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 212,516

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4,730

▲ € 3,714 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 192,524

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 206,316.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 6,751

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 121

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 43,519 Gross margin 2022: € 43,519 First fiscal year in the series	€ 23,672 Gross margin 2023: € 23,672 ▼ 46% vs 2022 (€ 43,519) Unfavourable step	€ 7,746 Gross margin 2024: € 7,746 ▼ 67% vs 2023 (€ 23,672) Unfavourable step	€ 12,183 Gross margin 2025: € 12,183 ▲ 57% vs 2024 (€ 7,746) Favourable step	▲ 57%
Profit after taxes	€ 27,809 Profit after taxes 2022: € 27,809 First fiscal year in the series	€ 12,433 Profit after taxes 2023: € 12,433 ▼ 55% vs 2022 (€ 27,809) Unfavourable step	€ 1,016 Profit after taxes 2024: € 1,016 ▼ 92% vs 2023 (€ 12,433) Unfavourable step	€ 4,730 Profit after taxes 2025: € 4,730 ▲ € 3,714 vs 2024 (€ 1,016) Favourable step	▲ € 3,714
Equity	€ 272,338 Equity 2022: € 272,338 First fiscal year in the series	€ 224,771 Equity 2023: € 224,771 ▼ 17% vs 2022 (€ 272,338) Unfavourable step	€ 207,786 Equity 2024: € 207,786 ▼ 8% vs 2023 (€ 224,771) Unfavourable step	€ 212,516 Equity 2025: € 212,516 ▲ 2% vs 2024 (€ 207,786) Favourable step	▲ 2%
Total debts	€ 46,213 Total debts 2022: € 46,213 First fiscal year in the series	€ 61,251 Total debts 2023: € 61,251 ▲ 33% vs 2022 (€ 46,213) Unfavourable step	€ 19,423 Total debts 2024: € 19,423 ▼ 68% vs 2023 (€ 61,251) Favourable step	€ 5,973 Total debts 2025: € 5,973 ▼ 69% vs 2024 (€ 19,423) Favourable step	▼ 69%
Cash	€ 231,559 Cash 2022: € 231,559 First fiscal year in the series	€ 196,630 Cash 2023: € 196,630 ▼ 15% vs 2022 (€ 231,559) Unfavourable step	€ 193,654 Cash 2024: € 193,654 ▼ 2% vs 2023 (€ 196,630) Unfavourable step	€ 192,524 Cash 2025: € 192,524 ▼ 1% vs 2024 (€ 193,654) Unfavourable step	▼ 1%
Retained profit	€ 266,138 Retained profit 2022: € 266,138 First fiscal year in the series	€ 218,571 Retained profit 2023: € 218,571 ▼ 18% vs 2022 (€ 266,138) Unfavourable step	€ 201,586 Retained profit 2024: € 201,586 ▼ 8% vs 2023 (€ 218,571) Unfavourable step	€ 206,316 Retained profit 2025: € 206,316 ▲ 2% vs 2024 (€ 201,586) Favourable step	▲ 2%
Dividend	€ 35,000 Dividend 2022: € 35,000 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 ▲ 71% vs 2022 (€ 35,000) Unchanged	€ 18,000 Dividend 2024: € 18,000 ▼ 70% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 18,000) Unchanged	▼ 100%
Balance sheet total	€ 318,551 Balance sheet total 2022: € 318,551 First fiscal year in the series	€ 286,022 Balance sheet total 2023: € 286,022 ▼ 10% vs 2022 (€ 318,551) Unchanged	€ 227,209 Balance sheet total 2024: € 227,209 ▼ 21% vs 2023 (€ 286,022) Unchanged	€ 218,489 Balance sheet total 2025: € 218,489 ▼ 4% vs 2024 (€ 227,209) Unchanged	▼ 4%

Key figures of CARDIODNFLUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CARDIODNFLUX?

What happened at CARDIODNFLUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 4,730 (▲ € 3,714 vs 2024). filed late Source: NBB ↗
Mar 19, 2002 Start of the company according to the CBE. KBO

In short

From € 27,809 profit in 2022 to € 4,730 profit in 2025.

Paid € 21,747 in corporate taxes since 2022.

Best year ever: 2022, with € 27,809 profit.

Paid out € 113,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Yvon DEHENEFFE

CARDIODNFLUX

Behind CARDIODNFLUX is Yvon DEHENEFFE.

Directors

According to the 2025 annual accounts

Yvon DEHENEFFE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Pêchières,Torgny 6

6767 Rouvroy

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0477.132.211
VAT number: BE 0477.132.211
Registered office: Rue Pêchières,Torgny 6, 6767 Rouvroy
Names & denominations: CARDIODNFLUX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 March 2002
Peppol: Not registered
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗